TianYu Bio-Technology Co (SHSE:603717) Cyclically Adjusted Revenue per Share: ¥3.35 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603717 TianYu Bio-Technology Co Ltd SHSE:603717
38 GF Score
Price ¥6.65
GF Value ¥6.02
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is TianYu Bio-Technology Co Cyclically Adjusted Revenue per Share?

TianYu Bio-Technology Co SHSE:603717 -0.30% 38 Cyclically Adjusted Revenue per Share is ¥3.35 as of Jun. 2026. GuruFocus rates SHSE:603717 with a GF Score™ of 38/100 and a GF Value™ of ¥6.02 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

TianYu Bio-Technology Co's adjusted revenue per share for the three months ended in Jun. 2026 was ¥0.677. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.35 for the trailing ten years ended in Jun. 2026.

During the past 12 months, TianYu Bio-Technology Co's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-02), TianYu Bio-Technology Co's current stock price is ¥6.65. TianYu Bio-Technology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ¥3.35. TianYu Bio-Technology Co's Cyclically Adjusted PS Ratio of today is 1.99.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TianYu Bio-Technology Co was 3.09. The lowest was 1.56. And the median was 2.18.


TianYu Bio-Technology Co  (SHSE:603717) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

TianYu Bio-Technology Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.65/3.35
=1.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TianYu Bio-Technology Co was 3.09. The lowest was 1.56. And the median was 2.18.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


TianYu Bio-Technology Co Cyclically Adjusted Revenue per Share Related Terms


TianYu Bio-Technology Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for TianYu Bio-Technology Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TianYu Bio-Technology Co Cyclically Adjusted Revenue per Share Chart

TianYu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 3.52 3.45

TianYu Bio-Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.49 3.46 3.45 3.49 3.35

SHSE:603717 vs PWR, FIX, EME: Cyclically Adjusted Revenue per Share Comparison

For the Engineering & Construction subindustry, TianYu Bio-Technology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TianYu Bio-Technology Co Cyclically Adjusted PS Ratio vs Construction Industry

For the Construction industry and Industrials sector, TianYu Bio-Technology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where TianYu Bio-Technology Co's Cyclically Adjusted PS Ratio falls into.


SHSE:603717
38GF Score
TianYu Bio-Technology Co Ltd SHSE:603717
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TianYu Bio-Technology Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TianYu Bio-Technology Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.677/116.0564*116.0564
=0.677

Current CPI (Jun. 2026) = 116.0564.

TianYu Bio-Technology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.616 102.400 0.698
201612 1.945 102.600 2.200
201703 1.128 103.200 1.269
201706 0.750 103.100 0.844
201709 0.672 104.100 0.749
201712 1.705 104.500 1.894
201803 0.659 105.300 0.726
201806 1.731 104.900 1.915
201809 0.770 106.600 0.838
201812 1.177 106.500 1.283
201903 0.704 107.700 0.759
201906 1.092 107.700 1.177
201909 0.750 109.800 0.793
201912 0.919 111.200 0.959
202003 0.362 112.300 0.374
202006 0.580 110.400 0.610
202009 0.882 111.700 0.916
202012 0.584 111.500 0.608
202103 0.572 112.662 0.589
202106 0.701 111.769 0.728
202109 0.469 112.215 0.485
202112 0.669 113.108 0.686
202203 0.425 114.335 0.431
202206 0.776 114.558 0.786
202209 1.022 115.339 1.028
202212 1.034 115.116 1.042
202303 0.651 115.116 0.656
202306 1.259 114.558 1.275
202309 0.415 115.339 0.418
202312 0.266 114.781 0.269
202403 0.727 115.227 0.732
202406 0.734 114.781 0.742
202409 0.690 115.785 0.692
202412 0.611 114.893 0.617
202503 0.777 115.116 0.783
202506 0.644 114.907 0.650
202509 0.436 115.471 0.438
202512 0.638 115.832 0.639
202603 0.531 116.303 0.530
202606 0.677 116.056 0.677

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥3.35 mean?
TianYu Bio-Technology Co (SHSE:603717) has a Cyclically Adjusted Revenue per Share of ¥3.35 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on TianYu Bio-Technology Co and its competitors.
Is TianYu Bio-Technology Co's Cyclically Adjusted Revenue per Share too high?
TianYu Bio-Technology Co's current Cyclically Adjusted Revenue per Share is ¥3.35. Overall, TianYu Bio-Technology Co has a GF Score™ of 38/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TianYu Bio-Technology Co's Cyclically Adjusted Revenue per Share compare to PWR and FIX?
TianYu Bio-Technology Co's Cyclically Adjusted Revenue per Share of ¥3.35 can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Construction company?
A good Cyclically Adjusted Revenue per Share depends on the Construction industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on TianYu Bio-Technology Co and its competitors. TianYu Bio-Technology Co's current Cyclically Adjusted Revenue per Share is ¥3.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TianYu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, TianYu Bio-Technology Co (SHSE:603717) is currently considered Fairly Valued. The stock's GF Value™ is ¥6.02, compared to a current price of ¥6.65 — trading 10.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥3.35. TianYu Bio-Technology Co's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For TianYu Bio-Technology Co (SHSE:603717), the current Cyclically Adjusted Revenue per Share is ¥3.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TianYu Bio-Technology Co (SHSE:603717) Overvalued in 2026?

Based on GuruFocus' analysis, TianYu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥6.65 is trading 10.5% above its estimated GF Value™ of ¥6.02. GuruFocus considers TianYu Bio-Technology Co to be Fairly Valued.

Key valuation signals for SHSE:603717:

  • Cyclically Adjusted Revenue per Share: ¥3.35
  • GF Value™: ¥6.02 vs. price of ¥6.65 (10.5% above fair value)
  • GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TianYu Bio-Technology Co Business Description

Address Lane 1688, Guoquan North Road, 2nd Floor, Building C4, Wangu Technology Park, Yangpu District, Shanghai, CHN, 200433
TianYu Bio-Technology Co Ltd is engaged in Garden ecological engineering business, ecological environment management and rural complex business, pig breeding business, production and marketing of agricultural products and cash crops.
38GF Score

Get the complete analysis for SHSE:603717

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.65
Price
¥6.02
GF Value